Authors/Disclosures
|
Jeffrey A. Wilken, PhD
(NAF)
|
No disclosure on file |
|
Moayd M. Al-Khalifah, MD
|
No disclosure on file |
|
Maziar Eslami, MD
(The Neurology group)
|
Dr. Eslami has nothing to disclose. |
|
Mitch T. Wallin, MD, MPH, FAAN
|
The institution of Dr. Wallin has received research support from NMSS. |
|
Sara Razmjou-Schwarz, MD
(Mclaren Macomb hospital)
|
No disclosure on file |
|
Cynthia L. Sullivan, PhD
(Neuropsychology Associates of Fairfax)
|
No disclosure on file |
|
Sheridan Reed
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Kathleen M. Zackowski, PhD, OTR
(National MS Society)
|
Dr. Zackowski has received personal compensation for serving as an employee of National MS Society. |
|
Samuel Lichtman-Mikol, BA
(Wayne State University)
|
Mr. Lichtman-Mikol has nothing to disclose. |
|
Anne Lodge
|
No disclosure on file |
|
Robert Kane, PhD, ABPP-CN
(Cognitive Consults and Technology LLC)
|
No disclosure on file |
|
Alexandros C. Tselis, MD, PhD
(WSU Sch of Med/Dept of Neur Health Ctr)
|
No disclosure on file |
|
Howard S. Rossman, DO
(Michigan Institute for Neurological Disorders)
|
No disclosure on file |
|
Christina Caon, RN, BS
(38 North Street)
|
Ms. Caon has received personal compensation for serving as an employee of EMD Serono. |
|
Sonda L. Lawson
(Michigan Institute for Neurological Disorders)
|
No disclosure on file |
|
Navid Seraji-Bozorgzad, MD
(University of Michigan Medicine-Neurology)
|
No disclosure on file |
|
James P. Simsarian, MD
|
No disclosure on file |
|
Evanthia Bernitsas, MD, FAAN
(Wayne State School of Medicine)
|
Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech. |
|
|
No disclosure on file |
|
Omar A. Khan, MD, PhD
(Dept of Neuro/Wayne State Univ Sch of Med)
|
No disclosure on file |
|
Robert K. Shin, MD, FAAN
|
Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sandoz. Dr. Shin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. |
|
Jerold Mikszewski, MD
|
No disclosure on file |
|
Douglas A. Kerr, MD, PhD
|
Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trace Neuroscience. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Spolia Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has or had stock in Dyne Therapeutics. |
|
|
No disclosure on file |